Calderon Gerardo Familiar Acquires 1,935 Shares of Chemours (NYSE:CC) Stock

The Chemours Company (NYSE:CC) insider Calderon Gerardo Familiar purchased 1,935 shares of Chemours stock in a transaction on Wednesday, August 12th. The shares were acquired at an average cost of $15.53 per share, with a total value of $30,050.55. Following the completion of the transaction, the insider directly owned 58,547 shares in the company, valued at $909,234.91. The trade was a 3.42% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Chemours Stock Performance

Shares of NYSE CC opened at $15.81 on Friday. The company has a 50 day simple moving average of $18.54 and a two-hundred day simple moving average of $20.00. The stock has a market cap of $2.38 billion, a price-to-earnings ratio of -8.28 and a beta of 1.43. The company has a current ratio of 1.66, a quick ratio of 0.88 and a debt-to-equity ratio of 18.98. The Chemours Company has a 12 month low of $10.44 and a 12 month high of $28.67.

Chemours (NYSE:CC) last released its quarterly earnings data on Tuesday, August 4th. The specialty chemicals company reported $0.42 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.07). The business had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.65 billion. Chemours had a negative net margin of 5.00% and a positive return on equity of 60.64%. The firm’s revenue was down 1.5% on a year-over-year basis. During the same period last year, the company earned ($2.54) earnings per share. As a group, analysts predict that The Chemours Company will post 0.88 earnings per share for the current year.

Chemours Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Friday, August 14th will be issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Friday, August 14th. Chemours’s dividend payout ratio is presently -18.32%.

Chemours News Summary

Here are the key news stories impacting Chemours this week:

• Positive Sentiment: Chemours is expanding its low-GWP Opteon refrigerant portfolio to address rising cooling demand from AI-driven data centers. The initiative could support growth in a higher-demand market while aligning with customers’ decarbonization goals. Zacks article on Chemours refrigerants for data centers
• Positive Sentiment: CEO Denise Dignam bought 3,378 shares for approximately $50,500, while insider Gerardo Familiar Calderon purchased 1,935 shares for roughly $30,000. The open-market purchases may suggest that insiders view the recent share-price weakness as an opportunity. SEC filing on CEO purchase SEC filing on insider purchase
• Neutral Sentiment: BMO Capital Markets cut its price target from $26 to $18 but maintained an “outperform” rating, leaving implied upside while signaling reduced expectations. The broader analyst consensus remains “hold,” with an average target near $20.10.
• Negative Sentiment: A securities-fraud investigation involving Chemours was announced, creating a potential legal and reputational overhang for shareholders. The announcement does not establish wrongdoing, but it may increase uncertainty around the company.
• Negative Sentiment: JPMorgan lowered its price target from $22 to $15 and kept a “neutral” rating, while Zacks Research downgraded the stock from “strong buy” to “strong sell.” These actions reinforce concerns following Chemours’ recent quarterly EPS and revenue misses. Benzinga report on JPMorgan target cut Zacks rating report

Institutional Trading of Chemours

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in Chemours in the second quarter valued at $477,769,000. Vanguard Group Inc. boosted its stake in shares of Chemours by 2.8% during the 4th quarter. Vanguard Group Inc. now owns 17,920,868 shares of the specialty chemicals company’s stock worth $211,287,000 after acquiring an additional 490,778 shares in the last quarter. State Street Corp boosted its stake in shares of Chemours by 22.7% during the 2nd quarter. State Street Corp now owns 6,114,328 shares of the specialty chemicals company’s stock worth $70,009,000 after acquiring an additional 1,131,682 shares in the last quarter. Ameriprise Financial Inc. grew its position in shares of Chemours by 13.8% during the 3rd quarter. Ameriprise Financial Inc. now owns 4,796,153 shares of the specialty chemicals company’s stock valued at $75,971,000 after acquiring an additional 580,089 shares during the period. Finally, UBS Group AG grew its position in shares of Chemours by 0.3% during the 3rd quarter. UBS Group AG now owns 4,754,492 shares of the specialty chemicals company’s stock valued at $75,311,000 after acquiring an additional 14,865 shares during the period. Institutional investors and hedge funds own 76.26% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on CC. Weiss Ratings lowered Chemours from a “sell (d)” rating to a “sell (d-)” rating in a research note on Thursday, August 6th. Royal Bank Of Canada decreased their price objective on Chemours from $26.00 to $22.00 and set an “outperform” rating for the company in a report on Thursday, August 6th. Mizuho set a $22.00 target price on Chemours in a research note on Wednesday, August 5th. Truist Financial dropped their target price on Chemours from $30.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. Finally, Alembic Global Advisors reiterated an “overweight” rating and set a $30.00 price target on shares of Chemours in a research report on Wednesday, May 13th. Five investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Chemours currently has an average rating of “Hold” and an average price target of $20.10.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.